Literature DB >> 1944613

Biphasic dose-response curves to arecoline in rat atria-mediation by a single promiscuous receptor or two receptor subtypes?

T P Kenakin1, C Boselli.   

Abstract

Arecoline produces a biphasic response in rat left atria, i.e., a depression of basal inotropy at low doses and a positive inotropic effect at higher doses. These present studies were designed to determine whether it can be shown that the two separate responses to arecoline are mediated by two distinct cell surface muscarinic receptors. The antagonists scopolamine, 4-DAMP and AF-DX 116 produced apparent simple competitive antagonism of the negative responses to arecoline. Schild analysis was used to measure the equilibrium dissociation constant of the antagonist-receptor complex for antagonism of this response to arecoline by these antagonists. In atria from rats treated with pertussis toxin, the negative inotropy to arecoline was abolished and only the positive inotropic effects were observed. The antagonism of the positive inotropic response to arecoline by these antagonists was studied separately in atria from rats treated with pertussis toxin by the Schild technique. The pKB estimates made from the Schild regressions indicated no evidence to suggest that the two responses to arecoline (negative and positive inotropy) were mediated by two separate receptors in rat left atria. These data are discussed in terms of a single muscarinic receptor in this tissue mediating these two responses by interaction with two G-proteins in the same cell membrane. These data also are discussed in terms of the use of agonist potency ratios for the classification of receptors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1944613     DOI: 10.1007/bf00167219

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  19 in total

Review 1.  Challenges for receptor theory as a tool for drug and drug receptor classification.

Authors:  T P Kenakin
Journal:  Trends Pharmacol Sci       Date:  1989-01       Impact factor: 14.819

2.  Indications for selective coupling to phosphoinositide hydrolysis or to adenylate cyclase inhibition by endogenous muscarinic receptor subtypes M3 and M4 but not by M2 in tumor cell lines.

Authors:  R Pinkas-Kramarski; R Edelman; R Stein
Journal:  Neurosci Lett       Date:  1990-01-22       Impact factor: 3.046

Review 3.  Are receptors promiscuous? Intrinsic efficacy as a transduction phenomenon.

Authors:  T Kenakin
Journal:  Life Sci       Date:  1988       Impact factor: 5.037

4.  Differences in muscarinic receptor reserve for inhibition of adenylate cyclase and stimulation of phosphoinositide hydrolysis in chick heart cells.

Authors:  J H Brown; D Goldstein
Journal:  Mol Pharmacol       Date:  1986-12       Impact factor: 4.436

5.  Agonists differentiate muscarinic receptors that inhibit cyclic AMP formation from those that stimulate phosphoinositide metabolism.

Authors:  J H Brown; S L Brown
Journal:  J Biol Chem       Date:  1984-03-25       Impact factor: 5.157

6.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

7.  Evidence for a carbachol stimulated phosphatidylinositol effect in heart.

Authors:  E E Quist
Journal:  Biochem Pharmacol       Date:  1982-10-01       Impact factor: 5.858

8.  GTP-binding proteins couple cardiac muscarinic receptors to a K channel.

Authors:  P J Pfaffinger; J M Martin; D D Hunter; N M Nathanson; B Hille
Journal:  Nature       Date:  1985 Oct 10-16       Impact factor: 49.962

9.  Uncoupling of cardiac muscarinic and beta-adrenergic receptors from ion channels by a guanine nucleotide analogue.

Authors:  G E Breitwieser; G Szabo
Journal:  Nature       Date:  1985 Oct 10-16       Impact factor: 49.962

10.  Positive inotropic effects induced by carbachol in rat atria treated with islet-activating protein (IAP)--association with phosphatidylinositol breakdown.

Authors:  S Imai; H Ohta
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

View more
  4 in total

1.  The action of (+/-)L-660,863 [(+/-)3-(3-amino-1,2,4-oxadiazole-5-yl)-quinuclidine] at muscarinic receptor subtypes in vitro.

Authors:  R M Eglen; G C Harris; A P Ford; E H Wong; J R Pfister; R L Whiting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-04       Impact factor: 3.000

2.  Characterization of muscarinic receptors mediating relaxation and contraction in the rat iris dilator muscle.

Authors:  Y Masuda; N S Yamahara; M Tanaka; S Ryang; T Kawai; Y Imaizumi; M Watanabe
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

3.  Inhibitory effect of dithiothreitol on angiotensin II-induced contractions mediated by AT1-receptors in rat portal vein and rabbit aorta.

Authors:  J S Zhang; J C van Meel; M Pfaffendorf; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-05       Impact factor: 3.000

4.  Pertussis toxin-sensitive muscarinic relaxation in the rat iris dilator muscle.

Authors:  N S Yamahara; M Tanaka; Y Imaizumi; M Watanabe
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.